Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             33 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab Tanner, M.

16 2 p. 273-278
artikel
2 A population-based assessment of the clustering of breast cancer in families eligible for testing of BRCA1 and BRCA2 mutations Lorenzo Bermejo, J.

16 2 p. 322-329
artikel
3 A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity Borner, M.M.

16 2 p. 282-288
artikel
4 Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications Puglisi, F.

16 2 p. 263-266
artikel
5 Biological modifiers as cytoreductive therapy before stem cell transplant in previously untreated patientswith multiple myeloma Avilés, A.

16 2 p. 219-221
artikel
6 Calreticulin expression in neuroblastoma—a novel independent prognostic factor Hsu, W.M.

16 2 p. 314-321
artikel
7 Cancer Chemoprevention Vol. 1. Promising Cancer Chemopreventive Agents van Zandwijk, N.

16 2 p. 337
artikel
8 Can patients with early-stage diffuse large B-cell lymphoma be treated without bone marrow biopsy? Lim, S.T.

16 2 p. 215-218
artikel
9 Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma Katsaros, D.

16 2 p. 300-306
artikel
10 Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years Au, W.-Y.

16 2 p. 206-214
artikel
11 Comparison of docetaxel and docetaxel–irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial Pectasides, D.

16 2 p. 294-299
artikel
12 Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes Stathopoulos, E.N.

16 2 p. 240-246
artikel
13 Development of axillary surgery in breast cancer Luini, A.

16 2 p. 259-262
artikel
14 Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives Spano, J.P.

16 2 p. 189-194
artikel
15 Evaluation of anemia, neutropenia and skin toxicities in standard or dose-dense doxorubicin/cyclophosphamide (AC)–paclitaxel or docetaxel adjuvant chemotherapy in breast cancer Schwartz, J.

16 2 p. 247-252
artikel
16 Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival Cleator, S.J.

16 2 p. 267-272
artikel
17 Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopenia van Tiel, F.H.

16 2 p. 195-205
artikel
18 Intra-arterial hepatic chemotherapy in heavily pretreated patients with epithelial ovarian cancer Mambrini, A.

16 2 p. 334-335
artikel
19 Juvenile cancer: improving care for adolescents and young adults within the frame of medical oncology Pentheroudakis, G.

16 2 p. 181-188
artikel
20 Long-term survival after surgical intervention for bone disease in multiple myeloma Zeifang, F.

16 2 p. 222-227
artikel
21 Multiple Myeloma and Related Disorders Bertolini, F.

16 2 p. 337
artikel
22 Obesity may decrease the amenorrhea associated with chemotherapy in premenopausal breast cancer patients Altundag, K.

16 2 p. 333
artikel
23 Outpatient management in patients with neutropenia after intensive chemotherapy—is it safe? Kern, W.V.

16 2 p. 179-180
artikel
24 Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma Thongprasert, S.

16 2 p. 279-281
artikel
25 Phase II study of troxacitabine in chemotherapy-naïve patients with advanced cancer of the pancreas Lapointe, R.

16 2 p. 289-293
artikel
26 Reply to the Letter to the Editor on “Obesity may decrease the amenorrhea associated with chemotherapy in premenopausal breast cancer patients”, by K. Altundag et al. (Ann Oncol 2005; 16: 333) Berclaz, G.

16 2 p. 333-334
artikel
27 Reply to the Letter to the Editor on ‘Severe hepatic sinusoidal obstruction and oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer: a real entity?’, by M. Sebagh, M. Plasse, F. Lévi & R. Adam (Ann Oncol 2005; 16: 331) Rubbia-Brandt, L.

16 2 p. 332-333
artikel
28 Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials Pagano, L.

16 2 p. 228-233
artikel
29 Serum HER2 extracellular domain in metastatic breast cancer patients treated with weekly trastuzumab and paclitaxel: association with HER2 status by immunohistochemistry and fluorescence in situ hybridization and with response rate Fornier, M.N.

16 2 p. 234-239
artikel
30 Severe hepatic sinusoidal obstruction and oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer: a real entity? Sebagh, M.

16 2 p. 331
artikel
31 Table of Contents
16 2 p. i-ii
artikel
32 The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy Bamias, A.

16 2 p. 307-313
artikel
33 Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer) Del Mastro, L.

16 2 p. 253-258
artikel
                             33 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland